11/27/2007

The BioCrossroadsLINX initiative, launched in October, has enabled pharmaceutical giants and Indiana-based biotech firms to partner on drug development-related services. Monarch LifeSciences, for instance, has increased its visibility and has helped other firms in the drug-validation process with the aid of the initiative.

Related Summaries